266 related articles for article (PubMed ID: 19444783)
21. Commercial support for continuing medical education.
Mamdani MB; Mamdani B
Issues Med Ethics; 1997; 5(2):43-5. PubMed ID: 16267900
[No Abstract] [Full Text] [Related]
22. A review of the federal guidelines that inform and influence relationships between physicians and industry.
Birkhahn RH; Jauch E; Kramer DA; Nowak RM; Raja AS; Summers RL; Weber JE; Diercks DB;
Acad Emerg Med; 2009 Aug; 16(8):776-81. PubMed ID: 19594459
[TBL] [Abstract][Full Text] [Related]
23. General Council to consider amendments to CMA policy on MDs' relationships with drug industry.
Williams JR
CMAJ; 1993 Aug; 149(3):335-7. PubMed ID: 11659649
[No Abstract] [Full Text] [Related]
24. Industry support and professional medical associations.
Jackson RH
JAMA; 2009 Aug; 302(7):738; author reply 739. PubMed ID: 19690304
[No Abstract] [Full Text] [Related]
25. Academic neurology and industry: open doors or firewalls?
Griffin JW
Nat Clin Pract Neurol; 2007 Jun; 3(6):297. PubMed ID: 17549056
[No Abstract] [Full Text] [Related]
26. Untainted by money.
Loehle C
New Sci; 1997 Aug; 155(2095):44. PubMed ID: 11656796
[No Abstract] [Full Text] [Related]
27. In diabetes fight, raising cash and keeping trust.
Santora M
N Y Times Web; 2006 Nov; ():A1, B4. PubMed ID: 17167875
[No Abstract] [Full Text] [Related]
28. Business and the academy.
Bok DC
Harv Mag; 1981; 83(5):23-35. PubMed ID: 11662883
[No Abstract] [Full Text] [Related]
29. From quid pro quo to quid pro bono: reshaping the influence of industry on health care epidemiologists.
Kirkland KB
Clin Infect Dis; 2010 Jan; 50(1):93-7. PubMed ID: 19951230
[TBL] [Abstract][Full Text] [Related]
30. Comment on: developing good scientific publishing practices: one pharmaceutical company's perspective.
Norris RA
Curr Med Res Opin; 2010 Jul; 26(7):1675-6. PubMed ID: 20450261
[No Abstract] [Full Text] [Related]
31. California campuses resist industry restrictions.
Check E
Nature; 2007 Jul; 448(7152):394-5. PubMed ID: 17653150
[No Abstract] [Full Text] [Related]
32. How skeptical should we be about industry-sponsored studies?
Meador KJ
Neurology; 2007 Apr; 68(15):1238; author reply 1238. PubMed ID: 17420417
[No Abstract] [Full Text] [Related]
33. CMA guidelines concerning relationship of MDs and drug industry to be revised, board told.
Sullivan P
CMAJ; 1993 Jan; 148(2):273-5. PubMed ID: 11652162
[No Abstract] [Full Text] [Related]
34. Trust, but verify.
Nature; 2009 Sep; 461(7262):315. PubMed ID: 19759574
[No Abstract] [Full Text] [Related]
35. Biomedical research and industry influence: some jasmine thoughts.
Bouzidi R; Kooli M
Orthopedics; 2011 Dec; 34(12):932-3. PubMed ID: 22147211
[No Abstract] [Full Text] [Related]
36. ACOG Committee Opinion No. 401: Relationships with industry.
American College of Obstetricians and Gynecologists Committee on Ethics
Obstet Gynecol; 2008 Mar; 111(3):799-804. PubMed ID: 18310391
[No Abstract] [Full Text] [Related]
37. Physicians' conflicts of interest.
Stell LK
APA Newsl Philos Med; 2003; 3(1):161-4. PubMed ID: 15115011
[No Abstract] [Full Text] [Related]
38. Guidelines for relationships between industry and the American College of Obstetricians and Gynecologists and its fellows. ACOG Committee Opinion No. 45.
American College of Obstetricians and Gynecologists [ACOG]. Committee on Ethics
ACOG Comm Opin; 1985 Oct; No. 45():1 p. PubMed ID: 11660326
[No Abstract] [Full Text] [Related]
39. A national survey of physician-industry relationships.
Grande D
N Engl J Med; 2007 Aug; 357(5):507-8; author reply 508. PubMed ID: 17674458
[No Abstract] [Full Text] [Related]
40. Industry support and professional medical associations.
Ray WL; Addleton RL
JAMA; 2009 Aug; 302(7):738; author reply 739. PubMed ID: 19690305
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
